focus -WSS

focus

author：hotspot 2025-10-01 02:14:56 - browse：84

close-up of psoriasis on a hand. -- biotech coverage from STAT — A close-up of psoriasis on a hand. Adobe

San Francisco startup Alumis Inc. has raised $259 million in a bid to best big pharma’s work in plaque psoriasis.

Alumis announced its Series C round Wednesday and plans to move its lead drug into Phase 3 trials. Venture firm Foresite Capital, which incubated Alumis, co-led the financing with Samsara BioCapital and venBio Partners.

Alumis’ lead drug, ESK-001, is an oral medicine designed to help patients with the most common type of psoriasis by inhibiting a signaling protein called TYK2. Research has shown that the TYK2 protein plays a role in diseases where the immune system overreacts, which has made it a popular drug target in recent years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Curing rare childhood diseases will falter unless Congress steps up

hotspot

WSS

How faith leaders like me can help address America's obesity epidemic

HIV drugs protect against transmission, even in unprotected sex

Pharma companies must ensure equitable access to obesity drugs

'Essentially witchcraft:' A former naturopath takes on the field

Medical device trials still don't enroll enough women, study finds

5 takeaways from STAT's examination of Zynex Medical

explore

focus

hotspot

Trump demands the U.S. pay no more for drugs than other countries … again

Lilly's Alzheimer's drug donanemab backed by FDA advisers

BioMarin wins approval for gene therapy to treat hemophilia A

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

Psychedelics group wrestles with new pharma identity

Shifting the focus from loneliness to social health

As demand for Covid shots wanes, Moderna seeks its next success

My daughter's legacy lives on through her writing, phage therapy

Virginia high school admissions case could be legal follow

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

hotspot

The Pandemic Treaty must support building strong health systems

Readers discuss the intersection of pregnancy and addiction

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

California wildfire smoke linked to 52,000 early deaths, study says

See how much Covid

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

hotspot

leisure time

focus

hotspot